No headlines found.
No press releases found.
No news found.
The Fund seeks to provide, at the end of the current Outcome Period, returns that track the share price returns of the SPDR S&P 500 ETF Trust (the "Underlying ETF") that are in excess of the Spread in positive market environments, while providing downside protection with a Buffer against the first 15% of Underlying ETF losses. The stated Spread and Buffer are before Fund fees and expenses. The current Outcome Period is from December 1, 2024 to November 30, 2025. The Fund pursues a buffered strategy that seeks to provide returns that track the share price returns of the SPDR S&P 500 ETF Trust (the "Underlying ETF") (i.e., the market price returns of the Underlying ETF), at the end of a specified one-year period, from December 1 to November 30.
Allianzim US Equity Buffer15 Uncapped Dec ETF trades on the BATS stock market under the symbol DECU.
As of April 21, 2026, DECU stock price declined to $27.94 with 30,605 million shares trading.
DECU has a beta of 0.66, meaning it tends to be less sensitive to market movements. DECU has a correlation of 0.93 to the broad based SPY ETF.
DECU has a market cap of $302.45 million. This is considered a Small Cap stock.
DECU has underperformed the market in the last year with a price return of +19.6% while the SPY ETF gained +35.2%. DECU has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +2.7% and +4.4%, respectively, while the SPY returned +4.2% and +6.9%, respectively.
DECU support price is $27.87 and resistance is $28.27 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DECU shares will trade within this expected range on the day.
